View Single Post
Old 01-02-2013, 12:10 PM   #2
Rolepaul
Senior Member
 
Join Date: Jan 2012
Location: Boulder Colorado as of January 2013
Posts: 391
Re: a large pooled analysis of benefit of herceptin beyond progression in Stage IVs

The problem is that CSF has a high turnover and that the concentration seen in my Xeloda/Tykerb treated patient CSF was still less than 10% of the blood concentration. High concentrations were found to be needed in the CSF to be effective. This was also true with three other patients that are seeing some success with IT Herceptin.
Rolepaul is offline   Reply With Quote